Download PDF
Clin Colon Rectal Surg 2014; 27(03): 91-98
DOI: 10.1055/s-0034-1384661
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Medical Management of Fecal Incontinence in Challenging Populations: A Review

David Lee
1   Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
,
Gaurav Arora
1   Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
2   Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas
› Author Affiliations
Further Information

Publication History

Publication Date:
24 September 2014 (online)

    Permissions and Reprints

Abstract

Fecal incontinence (FI) is a common and growing problem in the United States. Although there are multiple emerging novel interventions for the treatment of FI, the mainstay of initial therapy remains medical management. In this article, we review the available literature on the medical management of FI, with a special focus on patients with multiple sclerosis, diabetes mellitus, and the elderly.

Keywords

fecal incontinence - anorectal dysfunction - multiple sclerosis - diabetes mellitus - elderly
 

  • References

  • 1 Rao SS ; American College of Gastroenterology Practice Parameters Committee. Diagnosis and management of fecal incontinence. Am J Gastroenterol 2004; 99 (8) 1585-1604
    CrossrefPubMedGoogle Scholar
  • 2 Shah BJ, Chokhavatia S, Rose S. Fecal incontinence in the elderly: FAQ. Am J Gastroenterol 2012; 107 (11) 1635-1646
    CrossrefPubMedGoogle Scholar
  • 3 Whitehead WE, Borrud L, Goode PS , et al; Pelvic Floor Disorders Network. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 2009; 137 (2) 512-517 , e1–e2
    CrossrefPubMedGoogle Scholar
  • 4 Johanson JF, Lafferty J. Epidemiology of fecal incontinence: the silent affliction. Am J Gastroenterol 1996; 91 (1) 33-36
    PubMedGoogle Scholar
  • 5 Borrie MJ, Davidson HA. Incontinence in institutions: costs and contributing factors. CMAJ 1992; 147 (3) 322-328
    PubMedGoogle Scholar
  • 6 Sailer M, Bussen D, Debus ES, Fuchs KH, Thiede A. Quality of life in patients with benign anorectal disorders. Br J Surg 1998; 85 (12) 1716-1719
    CrossrefPubMedGoogle Scholar
  • 7 Bliss DZ, Jung HJ, Savik K , et al. Supplementation with dietary fiber improves fecal incontinence. Nurs Res 2001; 50 (4) 203-213
    CrossrefPubMedGoogle Scholar
  • 8 Lauti M, Scott D, Thompson-Fawcett MW. Fibre supplementation in addition to loperamide for faecal incontinence in adults: a randomized trial. Colorectal Dis 2008; 10 (6) 553-562
    CrossrefPubMedGoogle Scholar
  • 9 Sze EH, Hobbs G. Efficacy of methylcellulose and loperamide in managing fecal incontinence. Acta Obstet Gynecol Scand 2009; 88 (7) 766-771
    CrossrefPubMedGoogle Scholar
  • 10 Ouslander JG, Simmons S, Schnelle J, Uman G, Fingold S. Effects of prompted voiding on fecal continence among nursing home residents. J Am Geriatr Soc 1996; 44 (4) 424-428
    CrossrefPubMedGoogle Scholar
  • 11 Schnelle JF, Leung FW, Rao SS , et al. A controlled trial of an intervention to improve urinary and fecal incontinence and constipation. J Am Geriatr Soc 2010; 58 (8) 1504-1511
    CrossrefPubMedGoogle Scholar
  • 12 Schnelle JF, Alessi CA, Simmons SF, Al-Samarrai NR, Beck JC, Ouslander JG. Translating clinical research into practice: a randomized controlled trial of exercise and incontinence care with nursing home residents. J Am Geriatr Soc 2002; 50 (9) 1476-1483
    CrossrefPubMedGoogle Scholar
  • 13 Leung FW, Schnelle JF. Urinary and fecal incontinence in nursing home residents. Gastroenterol Clin North Am 2008; 37 (3) 697-707 , x
    CrossrefPubMedGoogle Scholar
  • 14 Cheetham M, Brazzelli M, Norton C, Glazener CM. Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev 2003; (3) CD002116
    PubMedGoogle Scholar
  • 15 Ehrenpreis ED, Chang D, Eichenwald E. Pharmacotherapy for fecal incontinence: a review. Dis Colon Rectum 2007; 50 (5) 641-649
    CrossrefPubMedGoogle Scholar
  • 16 Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS. Mechanism of the antidiarrheal effect of loperamide. Gastroenterology 1984; 86 (6) 1475-1480
    PubMedGoogle Scholar
  • 17 Read M, Read NW, Barber DC, Duthie HL. Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency. Dig Dis Sci 1982; 27 (9) 807-814
    CrossrefPubMedGoogle Scholar
  • 18 Hallgren T, Fasth S, Delbro DS, Nordgren S, Oresland T, Hultén L. Loperamide improves anal sphincter function and continence after restorative proctocolectomy. Dig Dis Sci 1994; 39 (12) 2612-2618
    CrossrefPubMedGoogle Scholar
  • 19 Sun WM, Read NW, Verlinden M. Effects of loperamide oxide on gastrointestinal transit time and anorectal function in patients with chronic diarrhoea and faecal incontinence. Scand J Gastroenterol 1997; 32 (1) 34-38
    CrossrefPubMedGoogle Scholar
  • 20 Regnard C, Twycross R, Mihalyo M, Wilcock A. Loperamide. J Pain Symptom Manage 2011; 42 (2) 319-323
    CrossrefPubMedGoogle Scholar
  • 21 Heykants J, Michiels M, Knaeps A, Brugmans J. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 5: the pharmacokinetics of loperamide in rats and man. Arzneimittelforschung 1974; 24 (10) 1649-1653
    PubMedGoogle Scholar
  • 22 Sadeque AJ, Wandel C, He H, Shah S, Wood AJ. Increased drug delivery to the brain by P-glycoprotein inhibition. Clin Pharmacol Ther 2000; 68 (3) 231-237
    CrossrefPubMedGoogle Scholar
  • 23 Scarlett Y. Medical management of fecal incontinence. Gastroenterology 2004; 126 (1) (Suppl. 01) S55-S63
    CrossrefPubMedGoogle Scholar
  • 24 Palmer KR, Corbett CL, Holdsworth CD. Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology 1980; 79 (6) 1272-1275
    PubMedGoogle Scholar
  • 25 Santoro GA, Eitan BZ, Pryde A, Bartolo DC. Open study of low-dose amitriptyline in the treatment of patients with idiopathic fecal incontinence. Dis Colon Rectum 2000; 43 (12) 1676-1681 , discussion 1681–1682
    CrossrefPubMedGoogle Scholar
  • 26 Carapeti EA, Kamm MA, Evans BK, Phillips RK. Topical phenylephrine increases anal sphincter resting pressure. Br J Surg 1999; 86 (2) 267-270
    CrossrefPubMedGoogle Scholar
  • 27 Cheetham MJ, Kamm MA, Phillips RK. Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut 2001; 48 (3) 356-359
    CrossrefPubMedGoogle Scholar
  • 28 Carapeti EA, Kamm MA, Nicholls RJ, Phillips RK. Randomized, controlled trial of topical phenylephrine for fecal incontinence in patients after ileoanal pouch construction. Dis Colon Rectum 2000; 43 (8) 1059-1063
    CrossrefPubMedGoogle Scholar
  • 29 Park JS, Kang SB, Kim DW, Namgung HW, Kim HL. The efficacy and adverse effects of topical phenylephrine for anal incontinence after low anterior resection in patients with rectal cancer. Int J Colorectal Dis 2007; 22 (11) 1319-1324
    CrossrefPubMedGoogle Scholar
  • 30 Carapeti EA, Kamm MA, Phillips RK. Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg 2000; 87 (1) 38-42
    PubMedGoogle Scholar
  • 31 Badvie S, Andreyev HJ. Topical phenylephrine in the treatment of radiation-induced faecal incontinence. Clin Oncol (R Coll Radiol) 2005; 17 (2) 122-126
    CrossrefPubMedGoogle Scholar
  • 32 Remes-Troche JM, Ozturk R, Philips C, Stessman M, Rao SS. Cholestyramine—a useful adjunct for the treatment of patients with fecal incontinence. Int J Colorectal Dis 2008; 23 (2) 189-194
    CrossrefPubMedGoogle Scholar
  • 33 Hinds JP, Eidelman BH, Wald A. Prevalence of bowel dysfunction in multiple sclerosis. A population survey. Gastroenterology 1990; 98 (6) 1538-1542
    PubMedGoogle Scholar
  • 34 Wiesel PH, Norton C, Glickman S, Kamm MA. Pathophysiology and management of bowel dysfunction in multiple sclerosis. Eur J Gastroenterol Hepatol 2001; 13 (4) 441-448
    CrossrefPubMedGoogle Scholar
  • 35 Norton C, Cody JD. Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults. Cochrane Database Syst Rev 2012; 7: CD002111
    PubMedGoogle Scholar
  • 36 Wiesel PH, Norton C, Roy AJ, Storrie JB, Bowers J, Kamm MA. Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000; 69 (2) 240-243
    CrossrefPubMedGoogle Scholar
  • 37 Munteis E, Andreu M, Martinez-Rodriguez J, Ois A, Bory F, Roquer J. Manometric correlations of anorectal dysfunction and biofeedback outcome in patients with multiple sclerosis. Mult Scler 2008; 14 (2) 237-242
    PubMedGoogle Scholar
  • 38 Preziosi G, Raptis DA, Storrie J, Raeburn A, Fowler CJ, Emmanuel A. Bowel biofeedback treatment in patients with multiple sclerosis and bowel symptoms. Dis Colon Rectum 2011; 54 (9) 1114-1121
    CrossrefPubMedGoogle Scholar
  • 39 Nusrat S, Gulick E, Levinthal D, Bielefeldt K. Anorectal dysfunction in multiple sclerosis: a systematic review. ISRN Neurol 2012; 2012: 376023
    PubMedGoogle Scholar
  • 40 Preziosi G, Gosling J, Raeburn A, Storrie J, Panicker J, Emmanuel A. Transanal irrigation for bowel symptoms in patients with multiple sclerosis. Dis Colon Rectum 2012; 55 (10) 1066-1073
    CrossrefPubMedGoogle Scholar
  • 41 Faaborg PM, Christensen P, Kvitsau B, Buntzen S, Laurberg S, Krogh K. Long-term outcome and safety of transanal colonic irrigation for neurogenic bowel dysfunction. Spinal Cord 2009; 47 (7) 545-549
    CrossrefPubMedGoogle Scholar
  • 42 Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983; 98 (3) 378-384
    CrossrefPubMedGoogle Scholar
  • 43 Epanomeritakis E, Koutsoumbi P, Tsiaoussis I , et al. Impairment of anorectal function in diabetes mellitus parallels duration of disease. Dis Colon Rectum 1999; 42 (11) 1394-1400
    CrossrefPubMedGoogle Scholar
  • 44 Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther 2001; 15 (1) 137-142
    CrossrefPubMedGoogle Scholar
  • 45 Wald A, Tunuguntla AK. Anorectal sensorimotor dysfunction in fecal incontinence and diabetes mellitus. Modification with biofeedback therapy. N Engl J Med 1984; 310 (20) 1282-1287
    CrossrefPubMedGoogle Scholar
  • 46 Kok AL, Voorhorst FJ, Burger CW, van Houten P, Kenemans P, Janssens J. Urinary and faecal incontinence in community-residing elderly women. Age Ageing 1992; 21 (3) 211-215
    CrossrefPubMedGoogle Scholar
  • 47 Chassagne P, Landrin I, Neveu C , et al. Fecal incontinence in the institutionalized elderly: incidence, risk factors, and prognosis. Am J Med 1999; 106 (2) 185-190
    CrossrefPubMedGoogle Scholar
  • 48 Read NW, Abouzekry L. Why do patients with faecal impaction have faecal incontinence. Gut 1986; 27 (3) 283-287
    CrossrefPubMedGoogle Scholar
  • 49 Tariq SH, Morley JE, Prather CM. Fecal incontinence in the elderly patient. Am J Med 2003; 115 (3) 217-227
    CrossrefPubMedGoogle Scholar
  • 50 Whitehead WE, Burgio KL, Engel BT. Biofeedback treatment of fecal incontinence in geriatric patients. J Am Geriatr Soc 1985; 33 (5) 320-324
    CrossrefPubMedGoogle Scholar